跳至主要内容
临床试验/NCT01890447
NCT01890447已完成不适用

Assessing Contacts' Decision Making on Reducing the Risk of Pertussis Transmission to Newborns Through Immunisation, in Italy and Spain

GlaxoSmithKline1 个研究点 分布在 1 个国家目标入组 676 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
676
试验地点
1
主要终点
The standard choice-based data will be used to assess the quality of the model fitted using the adaptive data. It will also be used for a qualitative comparison of adaptive (ACBC) and standard (CBC) data collection using descriptive approach.

研究概览

简要总结

This study aims to establish an effective method to inform parents or close relatives of newborns about the risk of pertussis transmission to newborns and the advantages offered by the cocooning strategy (vaccinating those who are in close contact with the newborn) by assessing the factors that affect the parents' decision-making to accept pertussis immunisation.

详细描述

Two phases are foreseen in the study. The 'questionnaire design' phase will be conducted in order to finalise the electronic questionnaire. The enrollment phase will involve the administration of the final web-based questionnaires to the subjects included in the enrollment phase.

The data generated in this study will be useful to inform parents of newborns about the advantages of vaccinating people who are in close contact with the newborn even before the baby is born in order to prevent the transmission of pertussis to the newborn.

No vaccine will be administered during this study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who the investigator believes that, can and will comply with the requirements of this protocol (ability to understand the study objectives and the questions asked, and ability to operate a computer).
  • Written informed consent obtained from the subject.
  • Subjects aged ≥ 18 years at the time of study start who are either:
  • Contacts of newborns (aged ≤ 6 months). OR Expecting mothers in their last trimester of pregnancy or their partners, who will be in close contact with the newborn.
  • Subjects who will be eligible for pertussis booster vaccination and have not received any pertussis vaccination in the last 2 years (before study start).

排除标准

  • Subjects who have participated in the 'questionnaire design' phase (applicable only for subjects who will participate in the enrollment phase of the study).
  • Subjects with a contraindication to pertussis vaccination.
  • Subjects who declare to be in principle against vaccination.
  • Subjects who declare to be in a chronic physical condition and not compatible with vaccination.
  • Subjects with a history of pertussis in the last 5 years (before study start).
  • History of non-response to pertussis vaccination.
  • Subjects with mental deficiency.
  • Subjects with unstable chronic health condition(s).

结局指标

主要结局

The standard choice-based data will be used to assess the quality of the model fitted using the adaptive data. It will also be used for a qualitative comparison of adaptive (ACBC) and standard (CBC) data collection using descriptive approach.

时间窗: After completion of the questionnaire by all the subjects (Visit 1 i.e. Day 0).

The primary endpoint constitutes the answers collected from all conjoint sections of the adaptive web-based questionnaire.

次要结局

  • The secondary endpoints constitute in all, the non-conjoint ancillary data collected through the web-based fixed questionnaire including, but not limited to: gender, age, family composition, education level and ethnicity.(After completion of the questionnaire by all the subjects (Visit 1 i.e. Day 0).)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Assessing Contacts' Decision Making on Reducing the... | 临床试验